Free Trial

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Sets New 12-Month High - Still a Buy?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation logo with Computer and Technology background

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - Get Free Report)'s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 1,698.30 ($21.85) and last traded at GBX 1,698.30 ($21.85), with a volume of 316 shares trading hands. The stock had previously closed at GBX 1,676.05 ($21.57).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Down 1.1 %

The firm has a market cap of £4.96 billion and a price-to-earnings ratio of -1,543.91. The company has a debt-to-equity ratio of 0.04, a current ratio of 9.42 and a quick ratio of 9.27. The firm's fifty day moving average is GBX 1,589.06 and its two-hundred day moving average is GBX 1,528.03.

About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

Read More

Should you invest $1,000 in First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation right now?

Before you consider First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation wasn't on the list.

While First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines